FOLFOX and FOLFIRI use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data

BACKGROUND: Shortly after the year 2000, randomized trials demonstrated that patients with metastatic colon cancer treated with infusional 5-fluorouracil (5FU)/leucovorin with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) had a comparable progression-free survival benefit versus patients who r...

Full description

Saved in:
Bibliographic Details
Published in:Clin Colorectal Cancer
Main Authors: Neugut, Alfred I., Lin, Aijing, Raab, Gabriel T., Hillyer, Grace Clarke, Keller, Deborah, O’Neil, Daniel S., Accordino, Melissa Kate, Kiran, Ravi P., Wright, Jason, Hershman, Dawn L.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379162/
https://ncbi.nlm.nih.gov/pubmed/30878317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2019.01.005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items